Intel Corporation

The stock remains in a long-term recovery regime, trading well above its 200-day moving average and far above the 52-week low. Even after a sharp pullback from the highs, the setup still reflects a powerful multi-month advance rather than a broken trend.

Street sentiment is cautious-to-neutral: consensus sits at Hold, while the average target near $87 implies downside from current levels. Recent action has been mixed, with several sharp target raises from Mizuho, Wells Fargo, Barclays, and Melius, but the latest rating change was a Jefferies downgrade to Hold.

The earnings backdrop is constructive but not clean. Intel has beaten EPS in 5 of the last 7 quarters, and next-year EPS is modeled to rise to $1.5451 from a negative TTM base. Shareholders should watch whether the next report extends the beat streak and supports the recovery narrative.

Recent activity leans to net selling, but most of the table is award and vesting noise from officers and directors. The only clear discretionary sale was by the Foundry CTO on 2026-05-29, while the CFO’s June activity included an in-kind transaction and exempt movements rather than open-market buying.

Profitability is improving but still uneven: gross margin is 37.2% and operating margin is 6.88%, while net margin remains negative at -5.9%. Revenue grew 7.2% year over year, and cash generation is solid with $9.697 billion of operating cash flow and $24.343 billion of free cash flow in 2025.

Intel still trades like a turnaround name versus semiconductor peers, with scale and foundry optionality offset by weaker current profitability. The valuation remains elevated on current earnings, while the market is pricing in a multi-year earnings reset rather than today’s margins.